|
Recent Publications By CRC Doctors
CATT Research Group
Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration
New England Journal of Medicine. April 2011.
Risard SM, Pieramici DJ, Rabena MD, Basefsky JC, Avery RL, Castellarin AA, Nasir MA, See RF, Couvillion SS
Intravitreal Ranibizumab For Macular Edema Secondary To Central Retinal Vein Occlusion
Retina. 2011 Jan 28.
Avery RL.
The Plague and Macular Degeneration.
Ophthalmology. December 2010.
Diabetic Retionpathy Clinical Research Network
Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema.Ophthalmology. June 2010
Pieramici D, Rabena M, Castellarin A, Nasir M, See R, Norton T, Sanchez A,
Risard S, Avery R.
Ranibizumab for the treatment of macular edema associated with perfused central retinal vein occlusions.
Ophthalmology. October 2008.
Arevalo JF, Maia M, Flynn H Jr, Saravia M, Avery RL, Wu L, Farah ME, Pieramici DJ,
Berroca MH, Sanchez JG.
Tractional Retinal Detachment following Intravitreal Bevacizumab (Avastin(R)) in patients with Severe Proliferative Diabetic Retinopathy.
J Ophthalmol. 2007 Oct 26
Avery RL
New treatments for age-related macular degeneration.
Lancet. 2007 Oct 27;370(9597):1479-80; author reply 1480.
No abstract available.
Avery RL, Pearlman J, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA, Giust MJ, Wendel R. Patel A.
Intravitreal bevacizumab (Avastin) in the treatment of proliferativediabetic retinopathy.
Ophthalmology.2006 Oct;113(10):1695.e1-1
Avery RL, Pieramici DJ, Rabena MD, Castellarin, AA, Nasir MA,Giust MJ.
Intravitreal Bevacizumab(Avastin) for Neovascular Age-Related Macular Degeneration Ophthalmology
Intravitreal Bevacizumab(Avastin) for Neovascular Age-Related Macular Degeneration Ophthalmology 2006 Mar;113(3):363-372e5
Avery RL.
Regression of Retinal and Iris Neovascularization Following Intravitreal Bevacizumab (Avastin)
Retina 2006. 26(3):352-354.
-No Abstract available-
Browning DJ, Glassman AR, Aiello LP, Beck RW, Brown DM, Fong DS, Bressler NM, Danis RP, Kinyoun JL, Nguyen OD, Bhavsar AR, Gottlieb J, Pieramici DJ, Rauser ME, Apte RS, Lim JI, Miskala PH.
Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema.
Ophthalmology.2007 Apr-May;27(4):525-36
Diabetic Retinopathy Clinical Research Network:
Gao BB, Clermont A, Rook S, Fonda SJ, Srinivasan VJ, Wojtkowski M, Fujimoto JG, Avery RL, Arrigg PG, Bursell SE, Aiello LP, Feener EP.
Extracellular carbonic anhydrase mediates hemorrhagic retinaland cerebral vascular permeability through prekallikrein activation.
Nat Med. 2007 Jan 28; [Epub ahead of print].
Huang C, Park S, Castellarin AA, Pieramici DJ,Cunningham ET jr.
Diagnostic and therapeutic challenges.
Retina. 2007 Mar;27(3):385-90.
Lewis GP, Betts KE, Sethi CS, Charteris DG, Lesnik-Oberstein SY, Avery RL, Fisher SK.
Identification of ganglion cell neurites in human sub- and epiretinalmembranes.
Br J Ophthalmol. 2006 Nov 15;
[Epub ahead of print]
Maia M, Pieramici DJ, Eong KG, Schachat AP, Rodrigues EB, Green WR.
Non-contiguous recurrence or secondary choroidal melanoma following plaque radiotherapy.
Clin Experiment Ophthalmol. 2007 Sep;35(7):657-60.
PMID: 17894687
Pieramici DJ, Avery RL
Ranibizumab: treatment in patients with Neovascular age-relatedmacular degeneration.
Expert Opin Biol Ther. 2006 Nov;6(11):1237-45.
Pieramici DJ, Avery RL, Castellarin AA, Nasir MA.
Case of anterior uveitis after intravitreal injection of bevacizumab.
Retina. 2006 Sep;26(7):841-2. -
No Abstract available-
Pieramici DJ, Rabena M, Castellarin AA, Nasir M, See R, Norton T, Sanchez A, Risard S, Avery RL.
Ranibizumab for the treatment of macular edema associated with perfused central retinal vein occlusions..
Ophthalmology. 2008 Oct;115(10):e47-54. Epub 2008 Aug 16.
Rabena MD, Pieramici DJ, Castellarin AA, Nasir MA, Avery RL.
Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion.
Retina. 2007Apr-May;27(4):419-25 .
Shahar J, Avery RL, Heilweil G, Barak A, Zemel E, Lewis G, et al.
Electrophysiologic and retinal penetration studies following intravitreal injection of bevacizumab (Avastin)
Retina. 2006. 26(3):262-269.
|
